| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-18 | 2009-09-30 | 13F-HR | Timber Hill Llc | No Data | | Sold All | -26,990 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Timber Hill Llc Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 43,585 | Added More | 17,908 | 69.74 % | $68,864 | $68,428 | $-436 | -0.63 % | $-179 | | | | | | News Article | History of Northern Trust Corp Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Rbc Dominion Securities Inc | Institution | 8,050 | No Change | 0 | 0 % | $12,719 | $12,639 | $-81 | -0.63 % | $0 | | | | | | News Article | History of Rbc Dominion Securities Inc Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wexford Capital Llc | Institution | 20,000 | New Holding | 20,000 | 100 % | $31,600 | $31,400 | $-200 | -0.63 % | $-200 | | | | | | News Article | History of Wexford Capital Llc Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Asset Management Investors Llc | Institution | 12,700 | No Change | 0 | 0 % | $20,828 | $19,939 | $-889 | -4.26 % | $0 | | | | | | News Article | History of Asset Management Investors Llc Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 5,086 | New Holding | 5,086 | 100 % | $8,341 | $7,985 | $-356 | -4.26 % | $-356 | | | | | | News Article | History of Barclays Plc Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 25,568 | No Change | 0 | 0 % | $41,932 | $40,142 | $-1,790 | -4.26 % | $0 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Oppenheimer And Co Inc | Institution | 26,621 | Sold Some | -7,274 | -21.46 % | $43,658 | $41,795 | $-1,863 | -4.26 % | $509 | | | | | | News Article | History of Oppenheimer And Co Inc Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 90 | Sold Some | -1,410 | -94.00 % | $148 | $141 | $-6 | -4.26 % | $99 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | | Sold All | -21,100 | -100 % | | | | -4.26 % | $1,477 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 348,468 | Added More | 38,260 | 12.33 % | $571,488 | $547,095 | $-24,393 | -4.26 % | $-2,678 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of America Corp | Institution | 81,000 | New Holding | 81,000 | 100 % | $132,030 | $127,170 | $-4,860 | -3.68 % | $-4,860 | | | | | | News Article | History of Bank Of America Corp Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 48,572 | Added More | 1,355 | 2.86 % | $79,172 | $76,258 | $-2,914 | -3.68 % | $-81 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 200 | New Holding | 200 | 100 % | $326 | $314 | $-12 | -3.68 % | $-12 | | | | | | News Article | History of Credit Suisse Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 15,339 | No Change | 0 | 0 % | $25,003 | $24,082 | $-920 | -3.68 % | $0 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | | Sold All | -23,640 | -100 % | | | | -3.68 % | $1,418 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Alphabet Management Llc | No Data | 2,058,172 | New Holding | 2,058,172 | 100 % | $3,334,239 | $3,231,330 | $-102,909 | -3.08 % | $-102,909 | | | | | | News Article | History of Alphabet Management Llc Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | 33,547 | Sold Some | -1,835 | -5.18 % | $54,346 | $52,669 | $-1,677 | -3.08 % | $92 | | | | | | News Article | History of Citigroup Inc Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | William Harris Investors Inc | Institution | 39,764 | No Change | 0 | 0 % | $64,418 | $62,429 | $-1,988 | -3.08 % | $0 | | | | | | News Article | History of William Harris Investors Inc Ownership Of Biosante Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | First New York Securities Llc | Institution | 19,100 | New Holding | 19,100 | 100 % | $29,414 | $29,987 | $573 | 1.94 % | $573 | | | | | | News Article | History of First New York Securities Llc Ownership Of Biosante Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 1,065 | No Compare | | | $1,619 | $1,672 | $53 | 3.28 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Biosante Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 535,320 | Sold Some | -22,791 | -4.08 % | $861,865 | $840,452 | $-21,413 | -2.48 % | $912 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Biosante Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 40,331 | No Change | 0 | 0 % | $72,999 | $63,320 | $-9,679 | -13.25 % | $0 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Biosante Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Harris Financial Corp | Institution | 71,205 | No Change | 0 | 0 % | $139,562 | $111,792 | $-27,770 | -19.89 % | $0 | | | | | | News Article | History of Harris Financial Corp Ownership Of Biosante Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 19,574 | No Change | 0 | 0 % | $37,974 | $30,731 | $-7,242 | -19.07 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Biosante Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | | Sold All | -300 | -100 % | | | | -19.07 % | $111 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Biosante Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Va Small Value Portfolio | Small-Cap Value | 92,699 | Sold Some | -63,063 | -40.48 % | $179,836 | $145,537 | $-34,299 | -19.07 % | $23,333 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Va Small Value Portfolio Ownership Of Biosante Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 47,217 | Added More | 12,242 | 35.00 % | $90,184 | $74,131 | $-16,054 | -17.80 % | $-4,162 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Biosante Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Microcap Index Fund | Specialty & Misc | 47,217 | Added More | 12,242 | 35.00 % | $87,351 | $74,131 | $-13,221 | -15.13 % | $-3,428 | | | | | | News Article | History of Ishares Trust - Ishares Russell Microcap Index Fund Ownership Of Biosante Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 198,586 | New Holding | 198,586 | 100 % | $381,285 | $311,780 | $-69,505 | -18.22 % | $-69,505 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Biosante Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 111,622 | Added More | 2,630 | 2.41 % | $214,314 | $175,247 | $-39,068 | -18.22 % | $-921 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Biosante Pharmaceuticals Inc |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss! There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |